SOPH
NASDAQSOPHiA GENETICS SA
Price$5.87+0.09 (+1.56%)
01:45 PM07:45 PM
News · 26 weeks151+133%
2026-01-182026-07-12
Mix6690d
- Insider46(70%)
- SEC Filings11(17%)
- Offering5(8%)
- Earnings2(3%)
- Other2(3%)
Latest news
25 items- INSIDERChief Scientific Officer Xu Zhenyu sold $22,819 worth of Ordinary Shares (4,000 units at $5.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.65% to 610,887 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Medical Officer Menu Philippe sold $28,505 worth of Ordinary Shares (5,000 units at $5.70) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 228,387 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERExecutive Chairman Camblong Jurgi sold $47,791 worth of Ordinary Shares (8,500 units at $5.62) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 3,532,622 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERExecutive Chairman Camblong Jurgi sold $93,327 worth of Ordinary Shares (17,685 units at $5.28) as part of a pre-agreed trading plan, decreasing direct ownership by 0.50% to 3,541,122 units (SEC Form 4) to satisfy tax liability4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Financial Officer Cardoza George sold $8,419 worth of Ordinary Shares (1,592 units at $5.29) as part of a pre-agreed trading plan, decreasing direct ownership by 0.51% to 309,092 units (SEC Form 4) (tax withholding)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief People Officer Valente Manuela sold $21,430 worth of Ordinary Shares (4,241 units at $5.05) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 210,450 units (SEC Form 4) (tax liability)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Technology Officer Verma Abhimanyu sold $26,957 worth of Ordinary Shares (5,285 units at $5.10) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 192,171 units (SEC Form 4) (tax liability)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Scientific Officer Xu Zhenyu sold $38,242 worth of Ordinary Shares (7,393 units at $5.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 614,887 units (SEC Form 4) (for withholding tax)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Sales Officer Puylaert Kevin sold $1,087 worth of Ordinary Shares (216 units at $5.03), decreasing direct ownership by 0.15% to 147,948 units (SEC Form 4) to satisfy withholding tax4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Executive Officer Muken Ross sold $51,354 worth of Ordinary Shares (9,838 units at $5.22) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 670,651 units (SEC Form 4) (tax withholding)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Medical Officer Menu Philippe sold $38,156 worth of Ordinary Shares (7,393 units at $5.16) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 233,387 units (SEC Form 4) (withholding tax)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERExecutive Chairman Camblong Jurgi sold $118,164 worth of Ordinary Shares (22,486 units at $5.25) as part of a pre-agreed trading plan, decreasing direct ownership by 0.63% to 3,558,807 units (SEC Form 4) to satisfy tax liability4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- SECSEC Form 144 filed by SOPHiA GENETICS SA144 - SOPHiA GENETICS SA (0001840706) (Subject)
- INSIDERExecutive Chairman Camblong Jurgi exercised 63,479 units of Ordinary Shares at a strike of $3.16 and sold $506,690 worth of Ordinary Shares (83,679 units at $6.06) as part of a pre-agreed trading plan, decreasing direct ownership by 0.56% to 3,581,293 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Executive Officer Camblong Jurgi sold $298,155 worth of Ordinary Shares (51,442 units at $5.80) as part of a pre-agreed trading plan and exercised 31,940 units of Ordinary Shares at a strike of $3.16, decreasing direct ownership by 0.54% to 3,601,493 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Technology Officer Verma Abhimanyu sold $38,229 worth of Ordinary Shares (6,944 units at $5.51) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 197,456 units (SEC Form 4) (withholding obligation)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Medical Officer Menu Philippe sold $27,524 worth of Ordinary Shares (5,000 units at $5.50) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 240,780 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERChief Financial Officer Cardoza George sold $4,164 worth of Ordinary Shares (774 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 0.25% to 310,684 units (SEC Form 4) to satisfy withholding obligation4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERPresident Muken Ross sold $2,270 worth of Ordinary Shares (422 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 0.06% to 680,489 units (SEC Form 4) (for withholding tax)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- SECSEC Form 144 filed by SOPHiA GENETICS SA144 - SOPHiA GENETICS SA (0001840706) (Subject)
- INSIDERDirector Cox Troy was granted 19,724 units of Ordinary Shares, increasing direct ownership by 6% to 328,743 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERDirector Ossipow Vincent was granted 19,724 units of Ordinary Shares, increasing direct ownership by 4% to 522,860 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERDirector Hibbs Kathy L was granted 19,724 units of Ordinary Shares, increasing direct ownership by 22% to 109,492 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERDirector Hirsch Didier was granted 19,724 units of Ordinary Shares, increasing direct ownership by 9% to 240,220 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
- INSIDERDirector Cossery Jean-Michel was granted 19,724 units of Ordinary Shares, increasing direct ownership by 11% to 206,212 units (SEC Form 4)4 - SOPHiA GENETICS SA (0001840706) (Issuer)
SOPH FAQ
7 questionsWhat does SOPHiA GENETICS SA do?
Sophia Genetics SA, a cloud-based software-as-a-service platform that enables healthcare institutions to get insights from their data. The company offers SOPHiA DDM for solid tumors. Sophia Genetics SA was founded in 2012 and is based in Saint-Sulpice, Switzerland.Where does SOPH stock trade?
SOPHiA GENETICS SA (SOPH) is listed on NASDAQ.What sector and industry is SOPH in?
SOPHiA GENETICS SA operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did SOPHiA GENETICS SA go public?
SOPHiA GENETICS SA (SOPH) completed its IPO in 2021.What are analysts saying about SOPH?
SOPHiA GENETICS SA has had 8 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $1100.00 price target on 2024-12-18.What companies are similar to SOPH?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare SOPH side-by-side with any of them on Quantisnow.How can I track SOPH on Quantisnow?
Quantisnow aggregates SOPHiA GENETICS SA's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SOPH to receive live email and push alerts on every new disclosure.